Bone scans may reveal how breast cancer subtypes spread

NCT ID NCT07750340

Not yet recruiting Knowledge-focused Sponsor: Sohag University Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This observational study looks at whether different molecular subtypes of breast cancer—like Luminal A, HER2-enriched, and triple-negative—show distinct patterns of bone metastasis on bone scans. Researchers will compare imaging results from 100 adults with breast cancer to see if certain subtypes tend to spread to specific bones. The goal is to better understand the link between tumor biology and where cancer travels in the skeleton.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If distinct patterns emerge, doctors might use breast cancer subtype to predict where bone metastases are likely, guiding more personalized imaging and follow-up.
What could go wrong: This is an observational study, so it can show associations but not prove cause. Results may not apply to all patients, and imaging patterns may overlap across subtypes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Faculty of Medicine Sohag University

Sohag, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.